Asosiy kontentga oʻtish
← Ishga qaytish

Ushbu ishga iqtibos qilgan ishlar

2 ta ish

Ish: Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study